+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07757230

Phase II Study of SSGJ-612 Combined With HER2-Targeted Antibody-Drug Conjugate in Hormone Receptor-Positive, HER2-Low or Ultralow Metastatic Breast Cancer

Led by Shenyang Sunshine Pharmaceutical Co., LTD. · Updated on 2026-10-14

87

Participants Needed

1

Research Sites

73 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a phase II clinical trial studying the combination of SSGJ-612 and a HER2-targeted antibody-drug conjugate ADC in patients with metastatic breast cancer that is hormone receptor-positive and has low or ultra-low HER2 expression. The study aims to assess treatment response and safety in this specific group of breast cancer patients, including those who have received chemotherapy and those who have not. The study is divided into two parts Part 1 includes breast cancer patients who have received at least one line of chemotherapy for metastatic disease, and Part 2 includes patients who have not received any chemotherapy for metastatic disease. Both SSGJ-612 and the HER2-targeted ADC are administered by intravenous injection. Treatment and monitoring extend up to two years to evaluate response and adverse events. Participants will undergo tumor assessments using RECIST v1.1 criteria to measure tumor lesions, along with evaluations of treatment safety and progression-free survival. The primary outcome is the objective response rate over two years, with secondary outcomes including adverse event incidence and severity, and progression-free survival. The study involves regular monitoring and assessments throughout the treatment period, which may last up to two years or until disease progression or other endpoints are reached.

CONDITIONS

Brief Title

A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer

Research Team

S

Shusen Wang M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here